Ligand · CQ5
CQ5 · 3-[[4-oxidanyl-1-[(3~{R})-3-phenylbutanoyl]piperidin-4-yl]methyl]-6-(2-pyrrolidin-1-ylethylamino)pyrimidin-4-one
CQ5, 3-[[4-oxidanyl-1-[(3~{R})-3-phenylbutanoyl]piperidin-4-yl]methyl]-6-(2-pyrrolidin-1-ylethylamino)pyrimidin-4-one (C26 H37 N5 O3, 467.6 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry). Every binding site…
- Component
- CQ5
- Formula
- C26 H37 N5 O3
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
CQ5 in 1 structure; the first of them:
- 6F5H · Crystal structure of USP7 in complex with a 4-hydroxypiperidine based inhibitor · CQ5 A1003 · binds TYR224, ASP295, VAL296, GLN297, LEU406, MET407, ARG408, PHE409 and 7 more
Residues it binds most
TYR 2, ASP 2, HIS 2, ARG 2, ASN 2, GLN 2, LEU 2, LYS 2, MET 2, PHE 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.